Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
    Next Article
    DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
    Mankind Pharma will be manufacturing 2-DG at its facilities in Visakhapatnam and Himachal Pradesh.

    DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG

    By Pratyush Deep Kotoky
    Jul 09, 2021
    03:01 am

    What's the story

    Pharmaceutical firm Mankind Pharma on Thursday announced that it has received approval from the Defence Research and Development Organisation (DRDO) to manufacture and market the COVID-19 drug 2-Deoxy-D-Glucose or 2-DG.

    The drug was developed by Defence Research Development Establishment (DRDE), Gwalior, and clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr. Reddy's Laboratories.

    Statement

    Aim is to ensure maximum reach of drug: Mankind Pharma

    Mankind Pharma, popular for its brands Manforce and Prega News, said in a statement on Thursday that it will manufacture the anti-COVID-19 drug at its facilities in Visakhapatnam and Himachal Pradesh.

    The company said, "Our objective behind this agreement is to ensure maximum reach of this medication to the deserving Indian patients suffering from the deadly pandemic."

    You're
    20%
    through

    Drug

    How effective is the drug against COVID-19?

    2-DG helps in the recovery of hospitalized patients and is recommended for moderate to severe COVID-19 patients under a physician's supervision as an adjunct therapy.

    It selectively accumulates in virus-infected cells and stops viral synthesis and energy production.

    The drug also alleviates cells from infection-induced cytopathic effects and cell death.

    It helps patients recover faster and reduces their dependence on supplemental oxygen.

    You're
    40%
    through

    Manufacture

    Apart from Mankind Pharma, who else is manufacturing the drug?

    Apart from Mankind Pharma, other companies such as Laurus Labs, Bajaj Healthcare have also received approvals to manufacture the drug.

    Another drugmaker, Shilpa Medicare, has also announced that it had received in-principle approval from DRDO.

    According to officials, since the drug is a generic molecule and analog of glucose, it can be easily produced and can be made available in plenty.

    You're
    60%
    through

    Price

    How much will it cost?

    The drug comes in powder form in a sachet and can be taken orally by dissolving it in water.

    Reportedly, the drug will be available in the market at a fixed price of Rs. 990.

    However, the DRDO will provide the drug for free to state and central governments.

    Notably, Dr. Reddy's has been producing the drug in limited quantity for hospitals.

    You're
    80%
    through

    Prescription

    Drug can be only used to treat moderate-severe patients

    2-DG, which was given approval for emergency use on May 1, can only be used to treat moderate to severe COVID-19 patients.

    While the drug is strictly prohibited to pregnant and lactating women and patients under 18 years, people with uncontrolled diabetes, cardiac problems, ARDS, severe hepatic and renal impairment are also advised to take caution before taking the drug.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Defence Research and Development Organisation (DRDO)
    Drugs Controller General of India
    Coronavirus

    Latest

    'Russia, Ukraine will immediately start ceasefire negotiations': Trump Donald Trump
    Decoding Premier League teams in race for Europe next season Premier League
    'Sirens,' 'Nine Perfect Strangers': Your OTT watchlist this week Amazon Prime Video
    'Fear Street: Prom Queen': Cast, plot, release details OTT releases

    Defence Research and Development Organisation (DRDO)

    Supersonic cruise missile BrahMos successfully test fired from Chandipur ITR India
    Railways to have 100% bio-toilets by 2019, says Piyush Goyal India
    Indo-Israel missile defense system to be procured by Israeli Navy India
    #ForeverOurHero: How Vajpayeeji made India a nuclear state India

    Drugs Controller General of India

    India may have a vaccine for dengue by 2019-end India
    GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance India
    #GoodNews: Pune's Mylab approved to make COVID-19 test kits India
    Remdesivir reportedly approved for COVID-19 treatment in India United States of America

    Coronavirus

    Guidelines for COVID-19 vaccination of pregnant women issued Union Ministry of Health and Family Welfare
    Centre's attitude toward migrant workers unpardonable, says Supreme Court Supreme Court Of India
    3 reasons why Uttarakhand HC stayed the Char Dham Yatra Uttarakhand High Court
    COVAXIN effectively neutralizes the Delta variant, top US body says COVID-19
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025